Introduction: Extracorporeal Membrane Oxygenation (ECMO) is a lifesaving procedure for patients with refractory cardiac or respiratory failure. The indications for ECMO are growing, and it is increasingly being used to support cardiopulmonary failure in children. However, the risks and benefits of ECMO should be weighed before deploying it on the patients. The objectives of this study were to identify the mortality risk factors and to determine the ECMO outcomes.Methods: The retrospective chart reviews were done for all patients aged 1 day−20 years old receiving ECMO between January 2010 and December 2020.Results: Seventy patients were enrolled in the study. The median age was 31.3 months. The incidence of VA and VV ECMO was 85.7 and 14.3%,...
Background/PurposeTo describe a single center’s experience with pediatric patients receiving extraco...
Nowadays, an increasing number of neonatal and pediatric patients with severe heart failure benefits...
Introduction : Around 3.2%–8.4% of patients receive venoarterial (VA) extracorporeal membrane oxygen...
Objective. To review demographic and procedural factors and their association with weaning rate and ...
ObjectivesIn children with cardiac disease, common indications for extracorporeal membrane oxygenati...
ObjectiveTo describe the use of extracorporeal membrane oxygenation (ECMO) in acute resuscitation af...
Background: Extracorporeal membrane oxygenation (ECMO) has become an important treatment modality in...
Aim To investigate the risk factors and the outcomes of extracorporeal membrane oxygenation (ECMO) i...
Introduction: In Portugal, extracorporeal membrane oxygenation (ECMO) is used in pediatric patients ...
Aim: To investigate the risk factors and the outcomes of extracorporeal membrane oxygenation (ECMO) ...
For children born with congenital heart defects (CHDs), extracorporeal life support may be necessary...
Abstract Background Veno-arterial extracorporeal membrane oxygenation (ECMO) is a common modality of...
extracorporeal membrane oxygenation-a case series Objective. To review demographic and procedural fa...
Extracorporeal membrane oxygenation (ECMO) is a general term that describes the short- or long-term ...
Extracorporeal membrane oxygenation (ECMO) has emerged as an effective mechanical support following...
Background/PurposeTo describe a single center’s experience with pediatric patients receiving extraco...
Nowadays, an increasing number of neonatal and pediatric patients with severe heart failure benefits...
Introduction : Around 3.2%–8.4% of patients receive venoarterial (VA) extracorporeal membrane oxygen...
Objective. To review demographic and procedural factors and their association with weaning rate and ...
ObjectivesIn children with cardiac disease, common indications for extracorporeal membrane oxygenati...
ObjectiveTo describe the use of extracorporeal membrane oxygenation (ECMO) in acute resuscitation af...
Background: Extracorporeal membrane oxygenation (ECMO) has become an important treatment modality in...
Aim To investigate the risk factors and the outcomes of extracorporeal membrane oxygenation (ECMO) i...
Introduction: In Portugal, extracorporeal membrane oxygenation (ECMO) is used in pediatric patients ...
Aim: To investigate the risk factors and the outcomes of extracorporeal membrane oxygenation (ECMO) ...
For children born with congenital heart defects (CHDs), extracorporeal life support may be necessary...
Abstract Background Veno-arterial extracorporeal membrane oxygenation (ECMO) is a common modality of...
extracorporeal membrane oxygenation-a case series Objective. To review demographic and procedural fa...
Extracorporeal membrane oxygenation (ECMO) is a general term that describes the short- or long-term ...
Extracorporeal membrane oxygenation (ECMO) has emerged as an effective mechanical support following...
Background/PurposeTo describe a single center’s experience with pediatric patients receiving extraco...
Nowadays, an increasing number of neonatal and pediatric patients with severe heart failure benefits...
Introduction : Around 3.2%–8.4% of patients receive venoarterial (VA) extracorporeal membrane oxygen...